Explore / Clinical trial
Clinical trial

Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients

Tel-Aviv Sourasky Medical CenterUnknownStarted Oct 1, 201050 enrolledIsraelNCT01207206

Abstract

In the current research the investigators would like to examine the effect of a well acquainted drug, Ketamine, which is used by anesthesiologists to induce sleep in operations. Usually the ketamine is given into the vein and not orally. The investigators want to give it orally to cancer patients that sufffer from severe pain to find out whether it can prove their quality of life, lower their pain and reduce the amount of opioids they receive.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePainPalliative care

Keywords

Patient suffering from severe cancer pain despite the opioid treatmentOpiate tolerance suspected on the basis of rapid escalation in opiate doseSevere opiate side effectsCancerTolerance

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.